Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Dr Shaw trained at Liverpool University Medical School and during this time received Medical Research Council funding to complete an intercalated Physiology degree. His general medical training in Bristol (Frenchay Hospital) lead him to work at the Royal Marsden Hospital and his interest in oncology.
He is dual trained in Clinical Oncology and Palliative Medicine (Oxford) with over 20 years experience of NHS care. His work based at Velindre Cancer Centre includes both the radical and palliative managements of patients with lung, oesophago-gastric and anal cancers. He is active in recruitment to clinical trials including local lead investigator roles for national lung (Matrix), anal cancer (Plato) and commercial trials. He is also the lead Clinical Oncologist for Early Phase Drug Radiation studies at Velindre Cancer Centre and is a Co-investigator for the developing UK Non-Small Cell Lung cancer study to test DNA damage and repair pathway inhibitors with radiation.
Dr Shaw combines full time NHS practice with academic responsibilities within the School of Bioscience, where he is an Honorary Senior Lecturer at Cardiff University. He completed PhD studies funded by the Cancer Research UK Bobby Moore Clinical Research Fellowship in Prof Alan Clarke’s laboratory (PhD awarded 2010). Since then he has Co-Supervised 3 PhD students at Cardiff University and has secured further funding to develop a lung cancer model with Oxford University to test drugs and radiotherapy combinations (PhD 2018-2021, Cancer Research Wales).
His complimentary NHS/Academic roles include being Co-chair of the Wales Cancer Partnership Lung Multi-Disciplinary Research Group, which aims to promote research collaborations across Wales. He is also a member of the Radiation Research Group at Velindre Cancer Centre and senior committee representative of the Cardiff Experimental Cancer Medicine Centre and member of CTrad science work stream.
Outside of work Dr Shaw likes to pursue an active lifestyle and is a very keen cyclist and loves nothing better than battling his way up some of the beautiful Welsh valleys on two wheels. He is happily married and loves living in Wales.
Fellow of the Royal College of Radiologists
Member of the Royal College of Physicians
CTRad science workstream committee member
Senior team member Cardiff ECMC
Dr Paul Shaw does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Paul Shaw does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Paul Shaw does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.